{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:10Z","timestamp":1785860350965,"version":"3.56.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.aco.0000192768.12206.08","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T04:02:22Z","timestamp":1142913742000},"page":"127-131","source":"Crossref","is-referenced-by-count":2,"title":["Transfusion therapy in the intensive care unit"],"prefix":"10.1097","volume":"19","author":[{"given":"Adrienne P.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1378\/chest.126.1.249","article-title":"Transfusion-related acute lung injury: a review","volume":"126","author":"Looney","year":"2004","journal-title":"Chest"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review","volume":"33","author":"Toy","year":"2005","journal-title":"Crit. Care Med."},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0265021505000633","article-title":"Transfusion-related acute lung injury: lack of recognition because of unawareness of this complication?","volume":"22","author":"Kram","year":"2005","journal-title":"Eur. J. Anaesthesiol."},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0310057X0503300318","article-title":"Severe transfusion-related acute lung injury in the intensive care unit secondary to transfusion of fresh frozen plasma","volume":"33","author":"Rajan","year":"2005","journal-title":"Anaesth. Intensive Care"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.0041-1132.2004.04194.x","article-title":"Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases in one hospital","volume":"44","author":"Nakagawa","year":"2004","journal-title":"Transfusion"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0958-7578.2004.00504.x","article-title":"Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation","volume":"64","author":"Nicolle","year":"2004","journal-title":"Transfus. Med."},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.0007-1048.2001.03305.x","article-title":"Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody","volume":"116","author":"Flesch","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"3","key":"R9-6-20210129","first-page":"487","article-title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic events in critically ill patients","volume":"33","author":"Silliman","year":"2005","journal-title":"Crit. Care Med."},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0025-6196(11)61531-0","article-title":"Transfusion-related acute lung injury","volume":"80","author":"Gajic","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1213\/01.ANE.0000138033.24633.4E","article-title":"Transfusion-related acute lung injury","volume":"99","author":"Toy","year":"2004","journal-title":"Anesth. Analg."},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/bja\/aeg101","article-title":"Transfusion-related acute lung injury (TRALI) \u2013 under-diagnosed and under-reported","volume":"90","author":"Wallis","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.TA.0000022460.21283.53","article-title":"Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis","volume":"54","author":"Hill","year":"2003","journal-title":"J. Trauma"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000542-200211000-00011","article-title":"Impact of alloantigens and storage-associated factors on stimulated cytokine response in an in vitro model of blood transfusion","volume":"97","author":"Biedler","year":"2002","journal-title":"Anesthesiology"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.6.5.652-657.1999","article-title":"Proposed mechanisms of transfusion-induced immunomodulation","volume":"6","author":"Kirkley","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.0958-7578.2004.00479.x","article-title":"Complement activation in prestorage leucocyte-filtered plasma","volume":"14","author":"Hyllner","year":"2004","journal-title":"Transfus. Med."},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0889-8537(05)70083-3","article-title":"Vascular access and fluid resuscitation in trauma: issues of blood and blood products","volume":"17","author":"Landers","year":"1999","journal-title":"Anesth. Clin. North. Am."},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood.V97.5.1180","article-title":"Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?","volume":"97","author":"Vamvakas","year":"2001","journal-title":"Blood"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00024382-200404000-00001","article-title":"Transfusion of the injured patient: proceed with caution","volume":"21","author":"Silliman","year":"2004","journal-title":"Shock"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jcrc.2001.21795","article-title":"Nutritional deficiencies and blunted erythropoietin response as a cause of the anemia of critical illness","volume":"16","author":"Rodriguez","year":"2001","journal-title":"J. Crit. Care"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","article-title":"Efficacy of recombinant human erythropoietin in critically ill patients","volume":"288","author":"Corwin","year":"2002","journal-title":"JAMA"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.CCM.0000155988.78188.EE","article-title":"Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients","volume":"33","author":"Shermock","year":"2005","journal-title":"Crit. Care Med."},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1034\/j.1399-3046.2003.00037.x","article-title":"The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation","volume":"7","author":"Rentoul","year":"2003","journal-title":"Pediatr. Transplant."},{"key":"R24-6-20210129","first-page":"151","article-title":"Aprotinin \u2013 a blood-saving substance","volume":"29","author":"Haas","year":"2002","journal-title":"Infus. Ther. Transfus. Med."},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2106\/00004623-200005000-00008","article-title":"Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement","volume":"82-A","author":"Murkin","year":"2000","journal-title":"J. Bone Joint Surg."},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00000542-199401000-00007","article-title":"High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery","volume":"80","author":"Janssens","year":"1994","journal-title":"Anesthesiology"},{"key":"R27-6-20210129","first-page":"74","article-title":"Transfusion-related cost of adjunct aprotinin application in one-step infected hip revision arthroplasty \u2013 cost-minimizing analysis","volume":"28","author":"Singlbartl","year":"2001","journal-title":"Infus. Ther. Transfus. Med."},{"key":"R28-6-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br. J. Haematol."},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00062752-200011000-00015","article-title":"New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate","volume":"7","author":"Kessler","year":"2000","journal-title":"Curr. Opin. Hematol."},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00008506-200310000-00008","article-title":"Use of activated recombinant factor VII (NovoSeven) during neurosurgery","volume":"15","author":"Karadimov","year":"2003","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/00000542-200206000-00040","article-title":"Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia","volume":"96","author":"Slappendel","year":"2002","journal-title":"Anesthesiology"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005176-200309000-00013","article-title":"Recombinant factor VIIa improves coagulopathy caused by liver failure","volume":"37","author":"Brown","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"R33-6-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00000542-200403000-00036","article-title":"Current concepts of hemostasis: implications for therapy","volume":"100","author":"Roberts","year":"2004","journal-title":"Anesthesiology"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0310057X0503300207","article-title":"Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy","volume":"33","author":"Gowers","year":"2005","journal-title":"Anaesth. Intensive Care"},{"key":"R35-6-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.CCM.0000159087.85970.38","article-title":"Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review (review)","volume":"33","author":"Levi","year":"2005","journal-title":"Crit. Care Med."},{"key":"R36-6-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00062752-200109000-00008","article-title":"Use of recombinant factor VIIa in hereditary bleeding disorders","volume":"8","author":"Poon","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"R37-6-20210129","first-page":"3","article-title":"Recombinant factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia A and inhibitors","author":"Hind","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl.","key":"R38-6-20210129","doi-asserted-by":"crossref","first-page":"S668","DOI":"10.1097\/01.CCM.0000099348.99451.84","article-title":"Transfusion practice in the critically ill","volume":"12","author":"Corwin","year":"2003","journal-title":"Crit. Care Med."},{"key":"R39-6-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.CCM.0000104112.34142.79","article-title":"The CRIT Study: anemia and blood transfusion in the critically ill \u2013 current clinical practice in the United States","volume":"32","author":"Corwin","year":"2004","journal-title":"Crit. Care Med."}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00132577-200609000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:22:53Z","timestamp":1785856973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001503-200604000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aco.0000192768.12206.08","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}